Risk Management


<< Back
Share
 Print

New and Updated Resources

April 5, 2023

Dear OMIC Insureds:

We are pleased to announce new and updated risk management resources:

Our updated Anti-VEGF Medications for Adults presents suggestions to increase patient safety and decrease the likelihood of lawsuits related to these drugs. It also provides information about our sample consent documents for anti-VEGF agents, including new sample consent forms for two biosimilar drugs, Byooviz™ and Cimerli™ .
 
We also have a new sample consent form for the steroid injection, Xipere®.

Coming Soon: a new sample consent form for Syforvre™, a treatment for geographic atrophy (GA).

If you have questions, contact us for confidential risk management advice at riskmanagement@omic.com or call us at 1-800-562-6642 and enter 4 for Risk Management.

Sincerely,

Jane Mock, CPHRM, OMIC Risk Manager

 

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment



Six reasons OMIC is the best choice for ophthalmologists in America.

Consistent return of premium.

Publicly-traded insurance companies exist to make profits for shareholders while physician-owned carriers often return profits to their policyholders. Don’t underestimate this benefit; it can add up to tens of thousands of dollars over the course of your career. OMIC has one of the most generous dividend programs for ophthalmologists and has returned more than $90 Million to our members through dividends.

61864684